|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 47/50 | (2017.01) |
| C07D 417/12 | (2013.01) | ||
| A61K 9/14 | (2006.01) | ||
| C07D 277/82 | (2013.01) | ||
| A61P 25/16 | (2006.01) | ||
| C07F 9/6541 | (2013.01) | ||
| C07D 417/12 | (2006.01) | ||
| A61K 31/428 | (2013.01) | ||
| C07D 277/82 | (2006.01) | ||
| A61P 21/00 | (2018.01) | ||
| A61P 25/02 | (2018.01) | ||
| A61P 25/16 | (2018.01) | ||
| A61P 43/00 | (2018.01) |
| (11) | Number of the document | 3377111 |
| (13) | Kind of document | T |
| (96) | European patent application number | 16867091.7 |
| Date of filing the European patent application | 2016-11-17 | |
| (97) | Date of publication of the European application | 2018-09-26 |
| (45) | Date of publication and mention of the grant of the patent | 2023-11-29 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2016/062400 |
| Date | 2016-11-17 |
| (87) | Number | WO 2017/087594 |
| Date | 2017-05-26 |
| (30) | Number | Date | Country code |
| 201562257533 P | 2015-11-19 | US |
| (72) |
MARFAT, Anthony , US
|
| (73) |
Biohaven Therapeutics Ltd. ,
215 Church Street, New Haven, CT 06510,
US
|
| (54) | AMINE PRODRUGS OF PHARMACEUTICAL COMPOUNDS |
| AMINE PRODRUGS OF PHARMACEUTICAL COMPOUNDS |